Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> A >> (2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide

(2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide
[CAS# 68748-55-0]

List of Suppliers
Glentham Life Sciences UK Inquire  
+44 (2033) 978-798
info@glenthamls.com
Chemical distributor since 2013
chemBlink standard supplier since 2013
Complete supplier list of (2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide
Identification
Name (2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide
Synonyms Antibiotic AM 6201; Antibiotic S 551II; Reductiomycin
Molecular Structure CAS # 68748-55-0, (2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide, Antibiotic AM 6201, Antibiotic S 551II, Reductiomycin
Molecular Formula C14H15NO6
Molecular Weight 293.27
CAS Registry Number 68748-55-0
Properties
Solubility Soluble (65 g/L) (25 ºC), Calc.*
Density 1.39±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2013 ACD/Labs)
Market Analysis Reports
List of Reports Available for (2E)-(+)-3-[5-(Acetyloxy)-4,5-dihydro-3-furanyl]-N-(2-hydroxy-5-oxo-1-cyclopenten-1-yl)-2-propenamide
Related Products
(1alpha)-17-(Acetyloxy)-6-chloro-1-(chloromethyl)pregna-4,6-diene-3,20-dione  3-(Acetyloxy)-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one  (11beta,16beta)-21-(Acetyloxy)-16-chloro-11,17-dihydroxy-pregna-1,4-diene-3,20-dione  (11beta,16alpha)-21-(Acetyloxy)-9-chloro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione  3-(Acetyloxy)cyclobutanone  2-(Acetyloxy)-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]benzamide  2-(Acetyloxy)cyclopropanecarboxylic acid methyl ester  (5alpha)-3-(Acetyloxy)-17-(cyclopropylmethyl)-4,5-epoxy-14-[[[[1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]amino]carbonyl]oxy]morphinan-6-one  (3beta,5alpha,11alpha,12beta,14beta,17alpha,)-12-(Acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy]-8,14-epoxy-11-(2-methyl-1-oxopropoxy)-pregnan-20-one  2-Acetyloxy-1-(2,4-difluorophenyl)ethanone  (11beta,16beta)-21-(Acetyloxy)-5',16-dihydro-11-hydroxy-pregna-1,4-dieno[17,16-c]pyrazole-3,20-dione  (2S,3S)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one  (2S-cis)-3-(Acetyloxy)-2,3-dihydro-2-(4-methoxyphenyl)-5-[2-(methylamino)ethyl]-1,5-benzothiazepin-4(5H)-one monohydrochloride  5-(Acetyloxy)-4,5-dihydro-2-methyl-3-furancarboxylic acid methyl ester  4-(Acetyloxy)-3,4-dihydro-1(2H)-naphthalenone  (2R,3S,6S)-3-(Acetyloxy)-3,6-dihydro-6-[2-(trimethylsilyl)ethynyl]-2H-pyran-2-methanol 2-acetate  (6beta,11beta)-21-(Acetyloxy)-11,17-dihydroxy-6-methylpregna-1,4-diene-3,20-dione  12-(Acetyloxy)-3,6-dihydroxy-7-oxocholan-24-oic acid methyl ester  (3alpha,5beta)-3-(Acetyloxy)-17,21-dihydroxy-pregnane-11,20-dione  3-[4-(Acetyloxy)-3,5-dimethoxycinnamic acid